209 related articles for article (PubMed ID: 37398932)
1. NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression.
Zhang H; Zhai X; Liu Y; Xia Z; Xia T; Du G; Zhou H; Franziska Strohmer D; Bazhin AV; Li Z; Wang X; Jin B; Guo D
Research (Wash D C); 2023; 6():0184. PubMed ID: 37398932
[TBL] [Abstract][Full Text] [Related]
2. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
[TBL] [Abstract][Full Text] [Related]
3. NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression.
Sun GF; Ding H
Neoplasma; 2023 Jun; 70(3):340-349. PubMed ID: 37498063
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA‑875‑5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a.
Chen T; Sun L; Yao B; Wang L; Wang Y; Niu Y; Liu R; Mo H; Liu Z; Tu K; Liu Q
Oncol Rep; 2020 Nov; 44(5):2067-2079. PubMed ID: 33000235
[TBL] [Abstract][Full Text] [Related]
5. Gankyrin drives metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human hepatocellular carcinoma.
Liu R; Li Y; Tian L; Shi H; Wang J; Liang Y; Sun B; Wang S; Zhou M; Wu L; Nie J; Lin B; Tang S; Zhang Y; Wang G; Zhang C; Han J; Xu B; Liu L; Gong K; Zheng T
Cancer Lett; 2019 Feb; 443():34-46. PubMed ID: 30503555
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic rRNA Modification by Yeast 5-Methylcytosine-Methyltransferases and Human Proliferation-Associated Antigen p120.
Bourgeois G; Ney M; Gaspar I; Aigueperse C; Schaefer M; Kellner S; Helm M; Motorin Y
PLoS One; 2015; 10(7):e0133321. PubMed ID: 26196125
[TBL] [Abstract][Full Text] [Related]
7. m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker.
Cui M; Qu F; Wang L; Liu X; Yu J; Tang Z; Cheng D
Cancer Biomark; 2022; 33(3):389-400. PubMed ID: 34744073
[TBL] [Abstract][Full Text] [Related]
8. Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2.
Wang F; Yuan JH; Wang SB; Yang F; Yuan SX; Ye C; Yang N; Zhou WP; Li WL; Li W; Sun SH
Hepatology; 2014 Oct; 60(4):1278-90. PubMed ID: 25043274
[TBL] [Abstract][Full Text] [Related]
9. SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis.
Xu K; Ding J; Zhou L; Li D; Luo J; Wang W; Shang M; Lin B; Zhou L; Zheng S
Cells; 2022 Dec; 12(1):. PubMed ID: 36611819
[TBL] [Abstract][Full Text] [Related]
10. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.
Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N
Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159
[TBL] [Abstract][Full Text] [Related]
11. Targeting ACYP1-mediated glycolysis reverses lenvatinib resistance and restricts hepatocellular carcinoma progression.
Wang S; Zhou L; Ji N; Sun C; Sun L; Sun J; Du Y; Zhang N; Li Y; Liu W; Lu W
Drug Resist Updat; 2023 Jul; 69():100976. PubMed ID: 37210811
[TBL] [Abstract][Full Text] [Related]
12. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition.
Luo W; Zhu X; Liu W; Ren Y; Bei C; Qin L; Miao X; Tang F; Tang G; Tan S
Oncotarget; 2016 Dec; 7(52):86420-86432. PubMed ID: 27861158
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma.
Wang M; Yang X; Meng Y; Jin Z; Cao J; Xiong L; Xiong Z
Int Immunopharmacol; 2023 Feb; 115():109660. PubMed ID: 36623412
[TBL] [Abstract][Full Text] [Related]
14. NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma.
Zhang XW; Wu LY; Liu HR; Huang Y; Qi Q; Zhong R; Zhu L; Gao CF; Zhou L; Yu J; Wu HG
Oncol Lett; 2022 Dec; 24(6):439. PubMed ID: 36420066
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
16. A functional loop between YTH domain family protein YTHDF3 mediated m
Zhou R; Ni W; Qin C; Zhou Y; Li Y; Huo J; Bian L; Zhou A; Li J
J Exp Clin Cancer Res; 2022 Dec; 41(1):334. PubMed ID: 36471428
[TBL] [Abstract][Full Text] [Related]
17. Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.
Jiang Y; Han Q; Zhao H; Zhang J
J Exp Clin Cancer Res; 2021 Jan; 40(1):13. PubMed ID: 33407720
[TBL] [Abstract][Full Text] [Related]
18. Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types.
Liu T; Zhang J; Lin C; Liu G; Xie G; Dai Z; Yu P; Wang J; Guo L
Front Cell Dev Biol; 2022; 10():839136. PubMed ID: 35372330
[No Abstract] [Full Text] [Related]
19. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
Yang X; Yang F; Lan L; Wen N; Li H; Sun X
Front Genet; 2022; 13():972043. PubMed ID: 36105093
[No Abstract] [Full Text] [Related]
20. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.
Zhang H; Su X; Burley SK; Zheng XFS
Theranostics; 2022; 12(7):3518-3533. PubMed ID: 35547764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
